AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
8.11
+0.51 (6.71%)
At close: Jul 2, 2026, 4:00 PM EDT
8.13
+0.02 (0.25%)
After-hours: Jul 2, 2026, 7:59 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $2.48 billion as of July 2, 2026. Its market cap has increased by 165.94% in one year.
Market Cap
2.48B
Enterprise Value
2.11B
1-Year Change
165.94%
Ranking
Category
Stock Price
$8.11
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $2.48B, a decrease of -84.19%. That is a compound annual growth rate of -28.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.48B | 141.92% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 2.64B |
| Trevi Therapeutics | 2.57B |
| Intellia Therapeutics | 2.56B |
| Immunome | 2.50B |
| Nurix Therapeutics | 2.47B |
| Kodiak Sciences | 2.45B |
| Biohaven | 2.42B |
| Mineralys Therapeutics | 2.41B |